Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
Clinical trial NCT05271552 · COMPLETED
Trial details
- NCT number
- NCT05271552
- Sponsor
- BioXcel Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-27
- Primary completion
- 2023-04-21
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.